NCT02182401View on ClinicalTrials.gov

Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2009

Conditions
Healthy
Interventions
DRUG

BI 207127 NA

Days 3-8 and days 25-30

DRUG

BI 201335 NA

Days 15-30

DRUG

Midazolam

Days 1, 7, 23 and 29

DRUG

Tolbutamide

Days 1, 7, 23 and 29

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY